At a glance
ClinicalIndex Comparison RecordN/ACompleted· 133 enrolled
Drug / intervention
GP1101device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Utility of GP1101 Relative to Surgical Bypass in the Treatment of Femoral / Popliteal Arterial Symptomatic Peripheral Arterial Disease
In Brief
A clinical study evaluating GP1101 for Peripheral Arterial Disease. Completed, enrolled 133 participants across 15 sites.
Detailed Summary
The utility of GP1101 will be evaluated relative to that of surgical bypass in the treatment of Femoral/Popliteal Arterial Symptomatic Peripheral Arterial Disease. Efficacy will be measured by comparison to a Surgical Bypass Efficacy Goal, and Invasiveness will be measured by comparison to Surgical Bypass data derived from a retrospective study.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedApr 2012
Primary CompletionAug 2014
Study CompletionFeb 2019
TodayJul 2026
First PostedApr 11, 2012
Enrollment StartApr 1, 2012
Primary CompletionAug 1, 2014
Study CompletionFeb 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.2 years ago
Interventions
GP1101device
Endovascular stent graft implantation